Clinical significance of protocadherin-8 (PCDH8) promoter methylation in bladder cancer. - Test2 - elhamkhani - TriplyDB

Clinical significance of protocadherin-8 (PCDH8) promoter methylation in bladder cancer.

Clinical significance of protocadherin-8 (PCDH8) promoter methylation in bladder cancer.

http://www.wikidata.org/entity/Q54264662

about

Protocadherin 17 promoter methylation in tumour tissue from patients with bladder transitional cell carcinoma Clinical significance of protocadherin 8 (PCDH8) promoter methylation in non-muscle invasive bladder cancer.Aberrant methylation of PCDH8 is a potential prognostic biomarker for patients with clear cell renal cell carcinoma.Urothelial cancer gene regulatory networks inferred from large-scale RNAseq, Bead and Oligo gene expression data.PCDH8 is Frequently Inactivated by Promoter Hypermethylation in Liver Cancer: Diagnostic and Clinical Significance.Altered methylation of glucosylceramide synthase promoter regulates its expression and associates with acquired multidrug resistance in invasive ductal breast cancer.Association between protocadherin 8 promoter hypermethylation and the pathological status of prostate cancer.PCDH8 inhibits glioma cell proliferation by negatively regulating the AKT/GSK3β/β-catenin signaling pathway.Promoter methylation of protocadherin8 is an independent prognostic factor for biochemical recurrence of early-stage prostate cancer.Aberrant methylation of protocadherin 17 and its clinical significance in patients with prostate cancer after radical prostatectomy Epigenome-wide analysis of DNA methylation reveals a rectal cancer-specific epigenomic signature.

P2860

Q28307954-A15965CD-48DD-42C1-B8C9-AB3BC3F933D0 Q34544542-1BD500E5-4B92-4706-A1AB-7FB3ABCDE165 Q34609542-C66CD4C1-B9F4-45DE-A123-4BA14EB5A0CF Q35630898-F0472AE4-5014-43B1-8924-7672457CE452 Q36567898-00305D8F-AC59-4F97-B01F-7FB5A050AD54 Q37392829-742CF99F-E16A-47D1-82BF-6BCD04C67380 Q41143113-D2B25BBF-CAB9-40BB-8366-9ABE7A2C12F3 Q41618797-ACF89C68-BC53-48DD-9293-A683B6305495 Q41833371-18283E15-8E6F-4E56-BE65-4761D23EC37E Q42804845-81FC12D0-7B1A-4E03-8220-92BA784BCB4D Q51568848-E45F8173-BD69-4635-BCFA-668DD38184AB

P2860

Clinical significance of protocadherin-8 (PCDH8) promoter methylation in bladder cancer.

http://www.wikidata.org/entity/Q54264662

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Clinical significance of protocadherin-8 (PCDH8) promoter methylation in bladder cancer.

@en

Clinical significance of protocadherin-8

@nl

type

label

Clinical significance of protocadherin-8 (PCDH8) promoter methylation in bladder cancer.

@en

Clinical significance of protocadherin-8

@nl

prefLabel

Clinical significance of protocadherin-8 (PCDH8) promoter methylation in bladder cancer.

@en

Clinical significance of protocadherin-8

@nl

P1433

Q54264662-961A551B-194E-43B2-8394-6A2B8EFFF37C

P1476

Q54264662-CE662665-04EE-4EE5-9926-3871BBE9A7D4

P2093

Q54264662-1511D85B-CEFB-4736-9A23-18DBF5D560DE

Q54264662-5381806F-8705-43C4-8758-29352CB56D68

Q54264662-57DA3188-62FE-4D51-A619-34FF84C6C0C6

Q54264662-64257725-B7AB-4C7D-9B65-1BDFF632567B

Q54264662-C5CE8D98-3BF1-4305-8FB7-C2DBB0C562A4

P2860

Q54264662-09A63B4A-A2D8-4B4B-A121-93F3709EB9F0

Q54264662-0DFAF946-D6B2-42F5-BCF7-5DAC4B3F7917

Q54264662-0F7D6679-73DF-4214-8E24-EA22D99893A6

Q54264662-126845F6-6483-47FF-8022-B3F96E3F0F29

Q54264662-187A852C-338E-4E5B-A2E9-19B8873D16D8

Q54264662-1B9EEFD0-D2C3-409A-85CC-7B884D5BA4CF

Q54264662-34ABF710-EB1D-4829-9303-F47519E12775

Q54264662-45BB856E-0C55-4006-88D8-D6DDE7371252

Q54264662-59C3EFE2-4DBA-4C8A-82EB-83F2A410E22B

Q54264662-87586A1D-2B67-4A98-AD67-B14BB4040E77

P304

Q54264662-CFF2293C-D08B-4F1B-B0F6-4CAEA733A861

P31

Q54264662-CEB0AB42-53A8-4EF9-BCEE-00C3C3D53B66

P356

Q54264662-876360D1-C8B2-4386-ACE8-AD8A9C09C5C1

P433

Q54264662-18A61D04-5198-4625-A4DC-8D7081B8EFA1

P478

Q54264662-59996DDC-CACA-4297-8D9C-A6D7A3A7C70D

P577

Q54264662-C758DCF9-B443-4C8A-8F6E-7ED726E39AEC

P5875

Q54264662-C1CF7594-A8D1-48B1-9390-457EBB18A36B

P698

Q54264662-8F437785-9546-416A-AD02-CD5B34541608

P356

0300060513475571

P1433

Journal of International Medical Research

P1476

Clinical significance of protocadherin-8 (PCDH8) promoter methylation in bladder cancer.

@en

P2093

Jian-Hua Ma

http://www.w3.org/2001/XMLSchema#string

Tong-Yu Guan

http://www.w3.org/2001/XMLSchema#string

Xiang-Li Luo

http://www.w3.org/2001/XMLSchema#string

Ying-Li Lin

http://www.w3.org/2001/XMLSchema#string

Zhi-Gang Li

http://www.w3.org/2001/XMLSchema#string

P2860

Characterization of two novel protocadherins (PCDH8 and PCDH9) localized on human chromosome 13 and mouse chromosome 14

Genomewide DNA methylation analysis reveals novel targets for drug development in mantle cell lymphoma.

Guidelines on bladder cancer.

Non-clustered protocadherin

Epigenetics of kidney cancer and bladder cancer.

Defining optimal therapy for muscle invasive bladder cancer.

Epigenetics in bladder cancer.

Germline prognostic markers for urinary bladder cancer: obstacles and opportunities.

Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy.

DNA methylation and cancer diagnosis: new methods and applications.

P304

48-54

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0300060513475571

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

41

http://www.w3.org/2001/XMLSchema#string

P577

2013-01-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236140550

http://www.w3.org/2001/XMLSchema#string

P698

23569129

http://www.w3.org/2001/XMLSchema#string